<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#Evidence> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#comment> "Cancer - Interactions investigated in the context of cancer dataset MI:0875"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#comment> "imex curation MI:0959"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#comment> "Only protein-protein interactions full coverage MI:0957"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#comment> "imex curation curation depth MI:0955"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#comment> "Cancer Cell (1535-6108) journal MI:0885"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#comment> "2012 publication year MI:0886"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#comment> "Yamaguchi T., Yanagisawa K., Sugiyama R., Hosono Y., Shimada Y., Arima C., Kato S., Tomida S., Suzuki M., Osada H., Takahashi T. author-list MI:0636"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#comment> "NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma."^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#comment> "tak@med.nagoya-u.ac.jp contact-email MI:0634"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IM-17130> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#UXR-EBI-6082759> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#PXR-22439932> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#experimentalForm> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_7772592468382090047> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> <http://www.biopax.org/release/biopax-level3.owl#experimentalForm> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_4559047260319726878> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_3118238329708085971> <http://www.biopax.org/release/biopax-level3.owl#evidence> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8686895784989599000> .